Clinical Trial: MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)

Sponsor and Collaborators
EMD Serono

Contact
Contact: Frank Campana, MD
+41-22-414-3000
frank.campana@merckserono.net

Principal Investigator
Study Director: Frank Campana, MD

ClinicalTrials.gov Identifier
NCT01085331